NYSE:PEN Penumbra Q2 2026 Earnings Report $317.86 +0.08 (+0.03%) Closing price 09/11/2026 03:58 PM EasternExtended Trading$317.73 -0.13 (-0.04%) As of 09/11/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Penumbra EPS ResultsActual EPS$0.88Consensus EPS $1.16Beat/MissMissed by -$0.28One Year Ago EPS$0.86Penumbra Revenue ResultsActual Revenue$390.05 millionExpected Revenue$389.64 millionBeat/MissBeat by +$402.00 thousandYoY Revenue Growth+14.90%Penumbra Announcement DetailsQuarterQ2 2026Date7/30/2026TimeAfter Market ClosesConference Call DateThursday, July 30, 2026Conference Call Time4:00PM ETUpcoming EarningsPenumbra's Q3 2026 earnings is estimated for Wednesday, November 4, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Penumbra Earnings HeadlinesFebruary 2027 lunar eclipse will be widely visible but barely noticeableSeptember 9 at 1:09 AM | msn.comIncuvate Files Patent Infringement Lawsuit Against PenumbraAugust 25, 2026 | markets.businessinsider.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.September 12 at 1:00 AM | Reagan Gold Group (Ad)Penumbra: Q2 Earnings SnapshotJuly 30, 2026 | chron.comPenumbra, Inc. Reports Second Quarter 2026 Financial ResultsJuly 30, 2026 | prnewswire.comMagnendo raises $18M to advance robotic platformJuly 27, 2026 | msn.comSee More Penumbra Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Penumbra? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Penumbra and other key companies, straight to your email. Email Address About PenumbraPenumbra (NYSE:PEN) (NYSE:PEN) is a medical device company that develops, manufactures and markets products designed to treat neurovascular, vascular and other medical conditions. Its technologies are used by physicians in minimally invasive procedures, including the removal of blood clots, treatment of aneurysms and management of vascular disorders. The company’s product portfolio includes aspiration and mechanical thrombectomy systems for ischemic stroke and pulmonary embolism, embolization devices for aneurysms and other vascular conditions, and access and peripheral vascular products. Penumbra also offers equipment and accessories that support interventional procedures. Founded in 2004 and headquartered in Alameda, California, Penumbra serves hospitals and healthcare providers in the United States and international markets. The company was founded by Adam Elsesser, who serves as its chairman, president and chief executive officer. Its products are distributed through direct sales organizations and other commercial channels worldwide.View Penumbra ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/07 - 09/11Kroger’s Textbook Entry for Buy-and-Hold InvestorsOracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in EarningsAmgen Drops 10% on a Trial It Didn't Even RunAST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing WindowAeroVironment's Record Backlog and Earnings Beat Fuel Recovery CaseBlock Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
